Cavin-2 promotes fibroblast-to-myofibroblast trans-differentiation and aggravates cardiac fibrosis.
Yusuke HiguchiTakehiro OgataNaohiko NakanishiMasahiro NishiYumika TsujiShinya TomitaSimon J ConwaySatoaki MatobaPublished in: ESC heart failure (2023)
Cavin-2 loss suppressed fibroblast trans-differentiation into myofibroblasts through the TGF-β/Smad signalling. The loss of Cavin-2 in cardiac fibroblasts suppresses cardiac fibrosis and may maintain cardiac function.